Time-restricted eating may be a safe and reasonable method for improving disease markers in people with Huntington disease.

An FDA panel supports Galleri, a blood test designed to detect multiple cancer types, despite some concern that the test is not reliable.

Pediatric patients receiving GLP-1 receptor agonist treatment appear to have higher rates of nutritional deficiency.

Multiple-component and multifactorial interventions do not meaningfully improve fall rates among older people compared with usual care.

Treatment with intravenous inebilizumab is associated with a significantly decreased risk for exacerbations in adults with generalized myasthenia gravis.

Initiating hormone replacement therapy near the onset of menopause may reduce the risk for LATE neuropathological changes in older women.

Continuous activity monitoring with wearable devices reveals that daily step count patterns correlate with disability severity in progressive MS.

A novel speech-based model successfully distinguishes between nonfluent, logopenic, and semantic variants of primary progressive aphasia.

Calculating brain-predicted age difference using MRI data helps identify patients with subjective cognitive decline at higher risk for dementia.

Women with cerebral palsy appear to receive significantly less preventive gynecologic care vs women that do not have cerebral palsy.

Most hospital readmissions following a subdural hematoma are driven by nonsurgical causes such as infections and cardiovascular conditions.

The FDA has approved Aqneursa (levacetylleucine) for ataxia in adult and pediatric patients with ataxia-telangiectasia weighing at least 15 kg.